(Press-News.org) HOUSTON -- The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory. Researchers from The University of Texas MD Anderson Cancer Center published the study results today in Nature Medicine.
The NEOSTAR trial tested combined neoadjuvant therapy of nivolumab plus ipilimumab, as well as neoadjuvant nivolumab monotherapy in patients with operable NSCLC. The trial met its prespecified primary endpoint efficacy threshold in the combination arm, with eight of 21 treated patients (38%) achieving major pathological response, defined as ?10% viable tumor at surgery. MPR has been shown to correlate with improved survival outcomes after neoadjuvant chemotherapy in NSCLC. The prespecified efficacy boundary for each treatment to be considered promising for further testing was six or more MPRs in 21 evaluable patients. With MPR in five of 23 treated patients (22%), monotherapy did not meet the efficacy boundary.
While combination immunotherapy has been approved for a subset of patients with metastatic NSCLC, this is the first randomized study to report on the role of combination checkpoint inhibitors for operable, early stage disease.
"More than 50% of patients with localized non-small cell lung cancer will relapse if treated with surgery alone. Adding chemotherapy produces only a modest improvement in overall survival, and it comes with toxicity," said Tina Cascone, MD., Ph.D., assistant professor of Thoracic/Head & Neck Medical Oncology and lead author of the study. "The results from our study with neoadjuvant combination immunotherapy are particularly encouraging in that we found that this dual treatment can induce higher pathologic responses and trigger immunological memory. This may translate into a reduced risk for tumor relapse in more patients with early stage non-small cell lung cancer."
Study design and secondary endpoints
The Phase II single-institution study enrolled 44 patients with surgically resectable stage IA to IIIA NSCLC between June 2017 and November 2018. The median age of trial participants was 66 years old, and 64% were male. Participants were 84% white, 9% Black and 5% Asian. Most participants had a history of smoking: 23% identified as current smokers and 59% as former smokers.
Patients were randomized to one of two treatment arms with immune checkpoint inhibitors prior to surgery: 23 received three doses of nivolumab alone and 21 received three doses of nivolumab plus one dose of ipilimumab. Each arm was compared against historical controls of neoadjuvant chemotherapy. Overall, 41 patients completed the planned three doses of therapies, 37 patients had surgery on trial and two patients underwent surgery off trial after additional therapies.
Among the 37 patients who had surgical resection on the study, the combination arm showed higher MPR rates (50% versus 24%) and fewer viable tumor cells at resection than monotherapy (a median of 9% versus 50%). Combination therapy also showed better pathological complete response rates than monotherapy (38% versus 10%). After a median follow-up of 22 months, median overall survival and lung cancer-related recurrence-free survival were not reached.
Toxicities were manageable overall, with no new safety concerns compared to known adverse event profiles of either drug. The median time to surgery was 31 days after the last dose of nivolumab. Some patients experienced nodal immune flare (NIF), or the appearance of nodal disease progression on radiographic imaging, which invasive node biopsy revealed to be immune cell infiltration rather than malignant disease.
Exploratory analyses reveal immune impact, potential biomarkers
In an exploratory analysis of resected tissues, investigators found -- and reported for the first time -- higher levels of immune cell infiltration in tumors treated with combination therapy, including an abundance of CD3+ and CD3+CD8+ T lymphocytes, tissue-resident memory and effector memory T cells. Tumors that responded better to treatment had higher PD-L1 expression at baseline, but responses were also observed in those without PD-L1 expression in tumor cells.
The researchers analyzed the gut microbiome, as well, and found that pathologic response to combination therapy was associated with the presence of certain fecal microbes that also have been correlated with immunotherapy response in melanoma and other cancers. Immune checkpoint inhibitor therapy did not significantly affect the diversity or composition of the microbiome in this study.
"Our exploratory results suggest the gut microbiome may play a role in responses to neoadjuvant immune checkpoint inhibitors in lung cancer," Cascone said. "The immune microenvironment findings also give us an opportunity to look at immune cell populations and potential biomarkers that can be evaluated in the future to identify those patients who are most likely to benefit from these agents in new prospective trials."
The NEOSTAR trial has been amended to a modular platform design, which provides the opportunity to add treatment arms to rapidly test and advance promising new neoadjuvant therapeutic combinations. Results from a third arm testing neoadjuvant nivolumab plus chemotherapy are expected later this year. A fourth arm testing the combination of dual immunotherapy plus chemotherapy is ongoing.
"The NEOSTAR trial results set the stage for evaluating the role of dual immunotherapy added to neoadjuvant chemotherapy, which we are currently exploring, and expediting the investigation of novel agents in the perioperative setting," Cascone said. "This is a population with potentially curable disease. We should do whatever it takes to minimize the risk of relapse and increase the cure rates for these patients."
INFORMATION:
The NEOSTAR trial was supported by the Lung Cancer Moon Shot®, part of MD Anderson's Moon Shots Program®, a collaborative effort designed to accelerate the development of scientific discoveries into clinical advances that save patients' lives. Boris Sepesi, M.D., associate professor of Thoracic and Cardiovascular Surgery, served as co-principal investigator of the study. A full list of co-authors and author disclosures can be found in the paper.
Additional research support was provided by Bristol Myers Squibb, the National Institutes of Health/National Cancer Institute (5P50CA070907, P30 CA016672), the American Society of Clinical Oncology's Conquer Cancer Foundation Career Development Award, the Connie Rasor Endowment for Cancer Research, the Bruton Endowed Chair in Tumor Biology, the Translation Molecular Profiling Immuno-profiling Laboratory, the MD Anderson Physician Scientist Program, the Khalifa Bin Zayed Al Nahyan Foundation, the Ford Petrin Donation, Rexanna's Foundation for Fighting Lung Cancer and the Bob Mayberry Foundation.
Throughout nature, there are instances of animals aiding one another and living together in mutually beneficial relationships that have helped shape the world's landscapes and biodiversity.
These domesticator-domesticate relationships form when one species provides multigenerational support to another species in exchange for a resource or service that benefits both species. An example of this type of relationship is how early humans domesticated gray wolves. The wolves were attracted to the human encampments, which provided them with protection and resources, and the wolves, in turn, helped the humans increase their hunting proficiency.
One area ...
Richer countries were more likely to see rates of COVID-19 fall faster during the first wave of the pandemic, according to new research published in the journal Frontiers in Public Health.
The study by Anglia Ruskin University (ARU) professors Shahina Pardhan and Nick Drydakis examined economic indicators in 38 European countries, such as Gross Domestic Product (GDP) per capita, life expectancy, and public spending, and the number of new coronavirus cases per million of the population between 1 April and 31 May 2020, using data from Our World in Data based on the seven-day rolling average of new cases for each country.
A significant negative correlation ...
UCLA RESEARCH ALERT
FINDINGS
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling (IFN). The team found that high type I IFN signaling is present in a subset of pancreatic tumors and it triggers a decrease in the level of NAD and NADH in pancreatic cancer cells, which are vital cofactors in critical metabolic processes.
After the researchers delineated the mechanism by which the NAD depletion occurs, they demonstrated that cells with high IFN signaling were more sensitive to NAMPT inhibitors, which inhibit a major pathway ...
NEW YORK, NY (Feb. 18, 2021)--A research team at the Center of Prevention and Evaluation (COPE) at Columbia University Irving Medical Center and the New York State Psychiatric Institute, led by Drs. Gary Brucato and Ragy R. Girgis, found that, contrary to popular belief, serious mental illness was present in only 11% of all mass murderers and in only 8% of mass shooters.
The study--the first published report on mass shootings from the Columbia Mass Murder Database--appeared online Feb. 17th in Psychological Medicine.
The investigators sought to gain much-needed insight into the relationship between serious mental ...
As climate change takes hold across the Americas, some areas will get wetter, and others will get hotter and drier. A new study of the yellow warbler, a widespread migratory songbird, shows that individuals have the same climatic preferences across their migratory range. The work is published Feb. 17 in Ecology Letters.
"What's amazing is that the birds track similar climates despite the fact that they have migrated thousands of miles," said Rachael Bay, assistant professor in the Department of Evolution and Ecology, College of Biological Sciences at the University of California, Davis. "It seems that individual birds may be adapted to particular ...
An international study in which the University of Granada participated--recently published in the journal Scientific Reports--has identified a new fossil record of these mysterious animals in the northeast of Taiwan (China), in marine sediments from the Miocene Age (between 23 and 5.3 million years ago)
These organisms, similar to today's Bobbit worm (Eunice aphroditois), were approximately 2 m long and 3 cm in diameter and lived in burrows
An international study in which the University of Granada (UGR) participated (recently published in the prestigious journal Scientific Reports) has revealed that the seafloor was inhabited by giant predatory worms during the Miocene Age (23-5.3 million years ...
Hip dysplasia is a developmental disorder common in most dog breeds, and its onset is affected by both hereditary and environmental factors.
Prior studies have identified dozens of genetic loci associated with hip dysplasia in various breeds. The relevance of the loci to disease susceptibility remains an open question. The previously identified loci were reinvestigated at the University of Helsinki, Finland, using a large independent cohort of 1,600 dogs representing ten breeds.
The individual genetic variants at the target loci were determined from blood samples. The standardized ...
While most adults over 50 understand that overuse of antibiotics is a problem, and say they're cautious about taking the drugs, a sizable minority have used antibiotics for something other than their original purpose, and appear to think the drugs could help treat colds, which are caused by viruses not bacteria.
These findings, contained in a new paper in Infection Control and Hospital Epidemiology, come from a national poll of people between the ages of 50 and 80 carried out as part of the National Poll on Healthy Aging.
The authors, from the University of ...
Cracow, 18 February 2021
Creation of matter in an interaction of two photons belongs to a class of very rare phenomena. From the data of the ATLAS experiment at the LHC, collected with the new AFP proton detectors at the highest energies available to-date, a more accurate - and more interesting - picture of the phenomena occurring during photon collisions is emerging.
If you point a glowing flashlight towards another one, you do not expect any spectacular phenomena. The photons emitted by both flashlights simply pass by each other. However, in certain collisions involving high-energy protons the situation is different. The ...
Air pollution levels may have exceeded air quality standards during the development of some Marcellus Shale natural gas wells in Pennsylvania, potentially impacting more than 36,000 people in one year alone during the drilling boom, according to Penn State scientists.
"The construction and drilling of these wells are a relatively short-term thing, and assessment of the impact on air quality is something that often falls through the cracks," said Jeremy Gernand, associate professor of industrial health and safety at Penn State. "But there are thousands and thousands of wells drilled depending on the year, and we wanted to see what the impact would be if we added it all up."
More than 20,000 unconventional Marcellus Shale gas wells have been drilled ...
